Leucadia National Corporation »

Horizon Therapeutics shares owned by Leucadia National Corporation

Quarter-by-quarter ownership of Horizon Therapeutics shares owned by Leucadia National Corporation from 13F filings

Historical chart of Leucadia National Corporation investment in Horizon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Horizon Therapeutics held by Leucadia National Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Horizon Therapeutics by Leucadia National Corporation

Quarter filed Position value Share count Share price at filing
2023-09-30 $21M 177k 115.69
2023-06-30 $0 339k 0.00
2023-03-31 $2.3M 21k 109.14
2022-12-31 $7.7M 68k 113.80

More positions owned by Leucadia National Corporation

Spdr Gold Tr Gold Shs (GLD)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Activision Blizzard
Delta Air Lines Inc Del Com New (DAL)
Ishares Tr Russell 2000 Etf (IWM)
Apple (AAPL)
Select Sector Spdr Tr Energy (XLE)
Palo Alto Networks (PANW)
Meta Platforms Cl A (META)
Spdr Ser Tr S&p Biotech (XBI)
Alphabet Cap Stk Cl A (GOOGL)
NVIDIA Corporation (NVDA)
Intel Corporation (INTC)

View all positions for Leucadia National Corporation

Top funds holding Horizon Therapeutics

IFP Advisors
Ronald Blue Trust
Beacon Capital Management
Huntington National Bank

View all funds holding Horizon Therapeutics